Sort
16,300 grants matching “fatty liver disease”
Role of extracellular vesicles in the regulation of immunometabolism in obesity
$571,634Takahisa Nakamura · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · DK
Impact of HIV co-infections and comorbidities on circadian rhythm in the liver
$571,625Eleftherios Michailidis · Emory University · DP1 · FY2024 · DK
Advancing MRI with an open inhomogeneous B0 magnet
$571,562R. Todd Constable · Yale University · R01 · FY2024 · EB
Prevention of Pediatric NAFLD in Hispanic Children
$571,406Jean A. Welsh · Emory University · R01 · FY2025 · NR
Coactivator P300 promotes hepatic steatosis in obesity
$571,325Ling He · Johns Hopkins University · R01 · FY2019 · DK
Genes and Gene Networks Associated with Obesity and Diabetes
$571,323Alan D Attie · University Of Wisconsin-Madison · R01 · FY2014 · DK
Genetic Requirements for the survival of Tubercle Bacilli in Nonhuman Primates
$571,220Deepak Kaushal · Tulane University Of Louisiana · R01 · FY2010 · AI
Insulin Signaling and Metabolic Regulation in Adipocytes
$571,175Michael P Czech · Univ Of Massachusetts Med Sch Worcester · R37 · FY2019 · DK
Insulin Signaling and Metabolic Regulation in Adipocytes
$571,175Michael P Czech · Univ Of Massachusetts Med Sch Worcester · R37 · FY2021 · DK
Insulin Signaling and Metabolic Regulation in Adipocytes
$571,175Michael P Czech · Univ Of Massachusetts Med Sch Worcester · R37 · FY2020 · DK
Synergistic effects of ECM and heterotypic crosstalk on cellular responses in non-alcoholic fatty liver disease
$571,118Salman R Khetani · University Of Illinois At Chicago · R01 · FY2025 · DK
Significance and mechanisms of hepatic ChREBPα induction via post-translational modifications in diet-induced NASH
$571,102Lei Yin · University Of Michigan At Ann Arbor · R01 · FY2022 · DK
Significance and mechanisms of hepatic ChREBPα induction via post-translational modifications in diet-induced NASH
$571,102Lei Yin · University Of Michigan At Ann Arbor · R01 · FY2021 · DK
Significance and mechanisms of hepatic ChREBPα induction via post-translational modifications in diet-induced NASH
$571,102Lei Yin · University Of Michigan At Ann Arbor · R01 · FY2023 · DK
Project 1 - Cardiometabolic Injury due to VOCs
$570,837Aruni Bhatnagar Bhatnagar · University Of Louisville · P42 · FY2025 · ES
Role of the nuclear estrogen-related receptor alpha in mitochondrial function
$570,764Michel Bernier · National Institute On Aging · ZIA · FY2011 · AG
Quantitative MRI and Deep Learning Technologies for Classification of NAFLD
$570,640Holden H Wu · University Of California Los Angeles · U01 · FY2024 · EB
Role of liver fat and fibrosis in human CVD risk phenotypes.
$570,618Rohit Loomba · University Of California, San Diego · P01 · FY2021 · HL
Regulation of Lipolysis by Oxytocin
$570,337Evan D Rosen · Beth Israel Deaconess Medical Center · R01 · FY2023 · DK
Role of liver fat and fibrosis in human CVD risk phenotypes.
$570,016Rohit Loomba · University Of California, San Diego · P01 · FY2020 · HL
Combination of ceramide and immunotherapy in treatment of hepatocellular cancer
$569,928Kevin Finnbar Staveleyo'carroll · University Of Missouri-Columbia · R01 · FY2020 · CA
Sulfur Amino Acid Metabolism in NAFLD
$569,509Satish C Kalhan · Cleveland Clinic Lerner Com-Cwru · R01 · FY2009 · DK
Insulin Stimulation of Hepatic Fatty Acid Synthesis via SREBP-1 c
$569,461Michael S Brown · Ut Southwestern Medical Center · P01 · FY2015 · HL
Targeting the orphan nuclear receptor LRH-1 with small molecules
$569,274Eric A Ortlund · Emory University · R01 · FY2023 · DK
Novel IP6K1 inhibitors for treatment of NAFLD/NASH
$569,142Xiaodong Wang · Univ Of North Carolina Chapel Hill · R01 · FY2025 · DK